Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report.

Brain Neurorehabil · 2023 · PMC10689866 · PMID 38047104

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a randomized controlled trial conducted in 2019 demonstrated that deferiprone slows down the progression of PKAN and is well-tolerated, the results did not reach statistical significance according to the employed scale [ 8 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.